Table 2.
Medications intake in two groups of Plasmapheresis and Control.
Medications | Plasmapheresis (n = 22) | Control (n = 22) | Dosage |
---|---|---|---|
Kaletra | 18 (81.8%) | 13 (59%) | P.O, Two tabs, twice a day (BD) for 14 days. |
Methylprednisolone | 18 (81.8%) | 0 | I.V, 50–250 mg, daily. |
Interferon (IFN) beta-1a 12000000 | 17 (77.3%) | 0 | S.C, Every other day for 5 doses. |
Atazanavir | 2 (9.1%) | 0 | P.O, 300 mg daily for 14 days |
Dexamethasone | 1 (4.5%) | 19 (86.4%) | I.V, 8 mg every 8 h, daily according to patient's status. |
Aspirin (ASA) | 4 (18.2%) | 0 | P.O, 80 mg daily. |
Vancomycin | 1 (4.5%) | 0 | I.V, 1 gr, twice a Day (BD) for 10 days. |
Meropenem | 1 (4.5%) | 0 | I.V, Meropenem 1gr every 8 h for 5 days. |